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ABSTRACT 
Title: Innovation in Healthcare, An analysis of the regional 
preconditions in Skåne for innovation in digital healthcare. 
 
Author: Oskar Fällman Karlsson 
 
Supervisors: Carl-Johan Asplund, Industrial Management and Logistics, 
Lund University, Faculty of Engineering, Sweden 
 
Ann Tronde, Project leader "Regional Digital Agendas for 
Healthcare", FoU-centrum Skåne, Skåne University Hospital 
Lund 
 
Problem 
formulation: 
The upcoming changes in the demographic structure will put 
pressure on the healthcare system in Skåne. Tax financed 
hospitals with more beds, doctors, nurses and other personnel 
will not be the solution to cope with the upcoming demands. 
Increasing healthcare productivity is one way, where digital 
healthcare is a potential part of the solution. 
 
One of the major limitations of the digital healthcare market 
is not the shortage of technology but rather the innovation-
uptake is slow in healthcare compared to other sectors. The 
problem is to understand why the technology uptake is slow, 
which barriers prevents uptake and what decelerate 
continued innovation in the healthcare sector. 
 
 
Purpose: 
 
The main purpose aim to describe and analyze the regional 
preconditions in Skåne for innovation in digital healthcare. 
The goal has been to identify strengths, opportunities and 
various barriers that prevents or delay innovation in the 
region. Identifying and proposing innovative health 
strategies with the TOWS-framework. 
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Sub purposes are to identify upcoming global trends in 
healthcare and gather a list of digital healthcare projects in 
the region.  
  
Methodology: 
 
The methodology for gathering data for this master thesis 
consists of a combination of primary and secondary data. 
Collected from secondary research, explorative quantitative 
survey study, semi structured interviews with key actors, 
attending and observing national and local eHealth events.  
  
Conclusions: 
 
The region of Skåne in the south of Sweden got the 
possibilities for a good climate for innovation in healthcare. 
There is a possibility to gather ideas and projects for 
incremental innovation in the region. Both the healthcare 
professionals and patients are sitting with valuable expertise 
and knowledge, which at this time is not fully utilized. To get 
a more radical change in the healthcare sector some barriers 
need to be broken down. These changes need a more 
strategic and political approach, many of them need to be 
brought up on a national level. Today security laws 
regulation the use of information need to be modified to 
allow the use of unidentified healthcare data. Making it 
easier for the academia and companies to use this 
information would allow them to pursue new research areas 
and possible innovations.  
 
For new entrepreneurs and businesses there is need to learn 
how to use the reimbursement model to support their 
business plans. It is also important that the way into the 
healthcare sector, procurements, is built to handle and 
promote these new ventures.  
 
Skåne has a gap in expertise regarding semantic 
interoperability, both in the business and academic sector. 
This is not a unique problem for Skåne and can be seen in 
other regions as well. Collaborations with other regions and 
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worldwide expertise is needed to fill this gap and promote 
advances in this field. 
Comparing to other countries, Sweden are ranked 3rd on the 
list of innovation uptake in healthcare just beaten by 
Denmark and Estonia. Third place in digital healthcare 
solution implementation is good but we can’t sit down and 
be satisfied with the result.  Even if you are in first place you 
need to constantly revaluate your position and look for areas 
to improve. The region have most of the building blocks to 
get a good climate for innovation in digital healthcare. 
Region Skåne have to join the blocks together, here is a 
unique opportunity to facilitate cross-border meetings, be a 
collaborate voice, and put digital healthcare on the agenda. 
There is a need for a link into healthcare to get providers, 
doctors and nurses to share their ideas and needs to business, 
entrepreneurs, and the academia. Lobbying to politicians and 
policymakers should be done to raise the awareness and try 
to change some regulations and laws that acts as barriers for 
innovation today. 
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Sammanfattning 
Titel: Innovation inom hälso- och sjukvården, en analys av de 
regionala förutsättningarna i Skåne för innovation inom 
digital hälsovård. 
 
Author: Oskar Fällman Karlsson 
 
Supervisors: Carl-Johan Asplund, Professor i Industriell ekonomi och 
logistik, Lunds universitet, Lunds Tekniska Sverige 
 
Ann Tronde, Projektledare "Regional Digital Agendas for 
Healthcare", FoU-centrum Skåne, Skånes 
universitetssjukhus Lund 
 
Problem-
formulering: 
De kommande förändringarna i den demografiska strukturen 
kommer att sätta press på sjukvården i Skåne. Skatte 
finansierade sjukhus med fler sängar, läkare, sjuksköterskor 
och annan personal kommer inte att vara lösningen för att 
klara de kommande kraven. Öka produktiviteten i vården är 
ett sätt, där digital hälsovård är en potentiell del av lösningen. 
 
En av de stora begränsningarna av marknaden för digital 
hälsovård är inte bristen på teknik utan snarare 
innovationsupptag är långsam i sjukvården jämfört med 
andra sektorer. Problemet är att förstå varför teknikupptaget 
är långsam, vilket hinder förhindrar upptag och vad saktar 
ner fortsatt innovation inom vårdsektorn. 
 
Syfte och 
delsyften: 
 
Syftet med examensarbetet är att beskriva och analysera de 
regionala förutsättningarna i Skåne för innovation inom 
digital hälsovård. Målet har varit att identifiera styrkor, 
möjligheter och olika hinder som förhindrar eller fördröja 
innovation i regionen. Identifiera och föreslå 
innovationsstrategier med hjälp utav TOWS-ramverket. 
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Delsyften är att identifiera kommande globala trenderna 
inom hälso- och sjukvården samt samla in en lista med e-
hälsoprojekt i regionen. 
 
Metodik: 
 
Metoden för att samla data till detta examensarbete består av 
en kombination av primär- och sekundärdata. Informationen 
är insamlade från sekundär forskning, explorativ kvantitativ 
enkätstudie, semistrukturerade intervjuer med nyckelaktörer, 
delta på nationella och lokala e-hälsoevenemang.  
 
Slutsatser: 
 
Regionen Skåne i södra Sverige har möjligheterna till ett bra 
innovationsklimat inom hälso- och sjukvården. Det finns 
möjligheter att samla idéer och projekt för inkrementell 
innovation i regionen. Både vårdpersonal och patienter sitter 
med outnyttjad värdefull kompetens och kunskap. För att få 
en mer radikal förändring inom sjukvården behöver vissa 
hinder brytas ner. Dessa förändringar behöver en mer 
strategisk och politisk strategi, många av dem måste föras 
upp på en nationell nivå. Dagens säkerhetslagar som reglerar 
användningen av information behöva ändras för att tillåta 
bruk av oidentifierade sjukvårdsuppgifter. Att göra det 
lättare för akademi och företag att använda denna typ av 
information skulle möjliggöra det för dem att satsa på nya 
forskningsområden och potentiella nya innovationer. 
 
För nya företagare och företag måste det framgå hur man 
använder befintlig ersättningsmodeller för att stödja sina 
affärsplaner. Det är också viktigt att vägen in i sjukvården, 
upphandlingar, är byggd för att hantera och främja nya 
satsningar. 
 
Skåne har en brist både inom näringslivet och den 
akademiska sektorn i kompetens avseende semantisk 
interoperabilitet, Detta är inte ett unikt problem för Skåne 
och kan ses i andra regioner. Samarbeten med andra regioner 
och världsomspännande kompetens behövs för att fylla detta 
gap och främja framsteg på detta område. 
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Jämfört med andra länder är Sverige rankat 3 på listan över 
av innovations upptag inom hälso- och sjukvården, slagen av 
Danmark och Estland. Tredje plats i implementering av 
digitala hälsolösningar är bra, men vi kan inte sitta ner och 
vara nöjda med resultatet. Även om du är på första plats 
måste du ständigt omvärdera din position och leta efter 
områden att förbättra. Regionen har de flesta byggstenarna 
för att nå ett bra innovationsklimat inom digital hälsovård. 
Region Skåne måste sätta ihop blocken, här finns ett unikt 
tillfälle att underlätta gränsöverskridande möten och satte 
digital hälsovård på agendan. Det finns ett behov av en länk 
in i sjukvården för att få professionen, läkare och 
sjuksköterskor att dela sina idéer och behov till företag, 
entreprenörer och den akademiska världen. Lobbying till 
politiker och beslutsfattare bör göras för att öka 
medvetenheten och försöka ändra de regler och lagar som 
fungerar som barriärer för innovation idag. 
  
Nyckelord: digital hälsovård, eHälsa, sjukvård, innovation, Skåne 
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Glossary 
Digital health 
Digital healthcare is transfer of health resources and healthcare services with use 
of information and communication technologies to help address the health 
problems and challenges. These technologies include both hardware and software 
solutions. Digital Health includes eHealth, mHealth, Wearables, EHR/EMR, 
Connected Health, Big Data, Quantified self, Interoperability, Health IT and 
many other. 
 
Figure 1the Digital Health Landscape 
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eHealth 
EHealth is one of the central terms that is commonly used today to describe a 
range of digital healthcare. There is many definitions of eHealth. For this master 
thesis the definition to be used are gathered from WHO and the European 
Commission “HEALTH-EU”. 
”eHealth is the overarching term for the range of tools based on information and 
communication technologies used to assist and enhance the prevention, 
diagnosis, treatment, monitoring, and management of health and lifestyle.” 
Broken down eHealth is the transfer of health resources and healthcare by 
electronic means. The three main areas are: 
• The delivery of health information with the help of Internet and 
telecommunications. 
• Using IT and electronic to improve public health services, e.g. through 
the education and training of health workers. 
• The use of electronic commerce and electronic business practices in 
health systems management. 
Mobile Health, mHealth, is a component of eHealth and was coin in 2005. The 
definition was used at the 2010 mHealth Summit of the Foundation for the 
National Institutes of Health (FNIH) was "the delivery of healthcare services via 
mobile communication devices". 
Innovation and Invention 
There is a distinct difference between innovation and invention. According to 
Innovation Unit, UK, Department of Trade and Industry (2004) innovation is the 
successful exploiting of new ideas. Which is a view shared by Tidd, Bessant and 
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Pavitt describing innovation as the process turning opportunity into new ideas 
and putting these into widely used practice. Invention is coming up with the new 
ideas, a new product, process or service in the first place. A new invention doesn’t 
guarantee commercial success and in many cases need innovations around it 
before getting adopted by the market.   
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 Introduction 
In this chapter the background and problem definition will be described. The 
purpose and delimitations of the thesis will be presented. This section ends with 
the disposition of the master thesis and a comprehensive work plan over the 
theoretical and empirical framework to give the reader an overview of the 
workflow.   
1.1 Background 
"We know that in healthcare we lag at least 10 years behind virtually every other 
area in the implementation of IT solutions. We know from a wide range of other 
services that  information technology applications can radically revolutionize 
and improve the way we do things" Estonian President Toomas Hendrik Ilves, 
Chair of the independent high-level eHealth Task Force (May 2012) 
Implementation of IT solutions and innovation in healthcare is lagging behind 
when compared to other sectors. These solutions have the possibility to change 
the way healthcare is performed today, and make it possible to cope with the 
future demands on the system. Reports shows that life expectancy is increasing 
and a growing proportion of the world’s population is living into old age. The 
result of people getting older are that people acquire more diseases during their 
life span, some of which are chronic and require more extensive and expensive 
healthcare. Taking the United States as an example, about 80% of all older adults, 
people above 65 years old, have one chronic condition, and 50% have at least 
two. Sweden is not far behind with the numbers 75% and 42%. These chronic 
diseases stands for 70% of today’s overall healthcare costs.  
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 Figure 2 Population aged 65+ in relation to the population aged 15-64  
A reason for this change is the upcoming “Silver Tsunami” which refers to the 
ageing workforce around the world. One of the driving factors for this 
phenomenon are the Post-World War II baby boom that created an unusually 
large birth rate during the years 1946 to 1964. These people have now got into 
their fifty’s and late sixty´s and are accounting for one part of the changing 
demographic pyramid. It has been predicted that in less than 50 years there will 
be just two persons of working age, between 15-64 years old, for every person 
above 65 in the European Union. Today that number are about 4:1, and the trend 
is similar around the world. 
 
Figure 3 Population pyramids, EU27, 2008 compared to 2060  
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The result of the changing demographic pyramid will be fewer future taxpayers 
and fewer people becoming doctors, nurses and other healthcare professionals 
compared to the total population. Thus, tax financed hospitals with more beds, 
and packed with doctors, nurses and other personnel will not be the solution to 
cope with the upcoming demands.  
 
1.2 Problem Definition 
The upcoming changes in the demographic structure will put pressure on the 
healthcare system. Tax financed hospitals with more beds, packed with doctors, 
nurses and other personnel will not be the solution to cope with the upcoming 
demands. Increasing healthcare productivity is one way, where digital healthcare 
and eHealth is a potential part of the solution. 
As Toomas Hendrik Ilves said, one of the major limitations of the digital 
healthcare market is not the shortage of technology but rather the innovation-
uptake is slow compared to other sectors.  
The problem is to understand why the technology- and innovation-uptake is slow, 
which barriers prevents uptake and what prevents faster innovation in the 
healthcare sector. 
1.3 Main purpose and sub purposes 
The main purpose aim to describe and analyze the regional preconditions in 
Skåne for innovation in digital healthcare. First sub purpose is to identify 
strengths, opportunities, weaknesses and threats to find various barriers that 
prevents or delay innovation in the region. Second sub purpose has been to 
applying the TOWS framework in order to propose a tentative future actions for 
digital health in south of Sweden 
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Intermediate goals are to identify upcoming global trends in healthcare and 
gather a list of digital healthcare projects in the region. 
1.4 Delimitations 
The geographical frame of this master thesis is limited to Skåne. The analysis 
will be based on the regional conditions and therefore may not be directly 
applicable to other regions. The thesis will consist of strategies based on the 
SWOT analysis of the region. Focus for the strategies will be on the triple helix 
and healthcare sector. 
1.5 Target Group 
The target groups for the master thesis are both the stakeholders in Region Skåne, 
the academia, politicians, healthcare and business sector.  
 
1.6 Disposition of the master thesis 
This section shows the disposition of the master thesis. Ending with a 
comprehensive work plan over the theoretical and empirical framework to give 
the reader an overview of the workflow.   
CHAPTER 1 – Introduction 
In this chapter the background and problem definition will be described. The 
purpose and delimitations of the thesis will be presented with a work plan over 
the theoretical and empirical framework.  
 
CHAPTER 2 – Research approach and methodology 
This chapter contains a description of the different methodology that can been 
used when gathering information. The research approach with the choice of 
methodology, research strategy and how information where gathered. 
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CHAPTER 3 – Theoretical framework 
The theoretical framework chapter describes the theories and models used for the 
analysis of the gathered empiric data. The framework consist of two methods that 
has been used in combination with each other to map the region, PESTEL and 
SWOT. The tool to form strategies from the SWOT analysis, TOWS, is described 
in the last section. 
 
CHAPTER 4 – Key areas of interest, Healthcare and ICT-challenges 
This chapter have a short summary explaining the different key ICT areas that 
has been identified as important for innovation in healthcare. They are security, 
semantic interoperability, cloud computing, pre-commercial procurement and 
big data. 
 
CHAPTER 5 – Background analysis of Skåne 
This chapter will present the current situation of Skåne and where it´s heading. It 
consist of a summary of the population growth, the regions vision, industries and 
a market analysis. The chapter includes a summary of the innovation support 
structure existing in region Skåne today.  
 
CHAPTER 6 – Upcoming trends 
This chapter describes upcoming global trends. These trends will affect how 
healthcare is going to be delivered both on a local and global level. Therefore is 
it important to have upcoming trends in mind when looking at new innovations, 
products and delivery systems.  
 
CHAPTER 7 – Summary of data 
The empiric chapter presents the gathered research data from the in-depth 
interviews and survey results. In the later part of the section all the gathered data 
including a PESTEL analyze are represented in the SWOT analyze of the region. 
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CHAPTER 8 – Analysis 
This chapter shows the analysis of the regional SWOT and the process to get 
strategies and action from it. The section ends with a broader analysis of the 
regional preconditions for innovation in digital healthcare. 
 
CHAPTER 9 – Conclusions and Recommendations 
This chapter presents the conclusions of the regional conditions in Skåne for 
innovation in digital healthcare. It ends with a list of complementary actions 
that that have come to light during the process. 
 
CHAPTER 10 – Reflections over main contributions 
This chapter adds some reflections regarding the innovation in healthcare in 
Skåne. The chapter ends with some interesting question has come to light during 
the process and could be considered topics for future academic research. 
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 Figure 4 the theoretical and empirical framework of the master thesis 
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 Research approach and methodology 
This chapter contains a description of the different methodology that can been 
used when gathering information and doing the analysis. The research approach 
with the choice of methodology, research strategy and how information where 
gathered. 
2.1 Research strategy 
Depending on the character of the report and the subject that’s going to be studied 
different research strategies may be applied. Here is a description of three of the 
most common research strategies, these strategies are often are used 
simultaneously. 
2.1.1 Exploratory 
In order to gain knowledge and understanding regarding a problem an 
exploratory strategy could be applied. The strategy can provide a foundation for 
relevant question formulations and enable specification of the task which in turn 
makes it possible to define different alternatives of action. 
According to Saunders there are three principal ways of conducting exploratory 
research:  
• Literature research 
• Interviewing key expert in the area 
• Conducting focus group interviews 
The advantage of an exploratory research method is that it is flexible and 
adaptable to change. When new data appear and new insights occur as a 
researcher you need to be willing to change the direction you are heading. 
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2.1.2 Descriptive 
Descriptive research is used when trying to provide an accurate description of 
observations of a phenomena. The objective of descriptive research is to map the 
terrain of a specific phenomenon. 
2.1.3 Explanatory 
Explanatory research aim to understand relationships between different variables. 
Studying a situation or a problem in order to explain the relationships that exist 
between dose variables. How different factors are connected and affect each other.  
2.2 Research method 
2.2.1 Quantitative research 
When preforming a quantitative research the goal is usually to find relations 
between different variables to able to make some type of generalization that later 
could be applied to populations beyond the sample population.  
Measurement is a central concept, it provides the ability to perform more exact 
estimations, describe small differences and finding significant causality. 
Examples of methods in quantitative research are surveys, structured interviews 
and structured observations. These methods enable the use of large sample 
populations.  
Quantitative data is collected at a distance with minimum interaction from the 
researcher. The researcher therefore has little to no influence on the result. This 
is critical in order to achieve reliability, see 2.4.1 Reliability.  
2.2.2 Qualitative research 
In contrary to quantitative research the objective of a qualitative data collection 
is to describe a certain situation by viewing it from the perspective of the research 
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subject. Data gathered in the process is often presented in the form of words. The 
results generated are often case specific and provide contextual understanding, 
but are difficult to generalize beyond the sample population. 
Examples of methods of collecting qualitative data are unstructured interviews 
and focus groups. Because of the nature of these methods it´s common when 
preforming a qualitative research to use a smaller sample population. It´s 
important to take into account the risk the researcher has of influencing the data 
that’s being collected. 
2.3 Data collection methods 
2.3.1 Survey 
A survey study is a type method to collect information in an organized and 
methodical way. The method is measuring of specific situations or conditions. 
The survey method is typically used for studies with descriptive or explanatory 
strategy allowing the collection of a large amount of data from a sizeable 
population in a highly economical way. The data is often obtained by using a 
questionnaire handed out to a sample population. The questionnaire is 
standardized which allows for easy comparison of the gathered data. 
It’s often used to collect quantitative data. The data collected can be used to 
suggest possible relationships between variables.  
To ensure reliability it´s important to spend time ensuring that the sample is 
representative for the population, designing and piloting the questionnaire to 
secure that the question is relevant and understandable.  This is a way to try to 
ensure a good response rate.  
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2.3.2 Interviews 
There are usually three different type of interviews that can be used when doing 
a research. Those are structured, semi-structured, and unstructured. There is some 
differences between them which makes them suitable for various intents and 
purposes. 
2.3.2.1 Structured interviews 
Structured interviews require to follow a very particular set of rules. Each 
question that is outlined should be read word for word by the researcher without 
any deviation from the protocol. In some cases, the interviewer is also required 
to show consistency in behavior across all interviews. This includes body posture, 
facial expressions, and emotional affect. Reactions to participant responses 
should be kept to a minimum or if possible avoided entirely. 
Structured interviews are the type used most often by quantitative researchers. 
The style is useful when looking for very specific information. The benefits are 
that it keeps the data concise and reduces researcher bias. 
 
2.3.2.2 Semi-structured interviews 
Semi-structured interviews are a bit more relaxed than structured interviews. 
While researchers using this type are still expected to cover every question in the 
protocol, they have some wiggle room to explore participant responses by asking 
for clarification or additional information. Interviewers also have the freedom to 
be more friendly and sociable. 
Semi-structured interviews are most often used in qualitative studies. The style 
is most useful when one is investigating a topic that is very personal to 
participants. Benefits include the ability to gain participants' trust, as well as a 
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deeper understanding of responses. Data sets obtained using this style will typical 
be larger than those with structured interviews.  
2.3.2.3 Unstructured interviews 
In this type of interviews researchers only need a checklist of topics that should 
be covered during the interview. There is no order and no script. The interaction 
between the participant and the researcher is more like a conversation than an 
interview. 
Unstructured interviews are most often used in qualitative studies. They are best 
used when researchers want to find as much information as possible about their 
topic. The benefit is that unstructured interviews often uncover information that 
would not have been exposed using structured or semi-structured interviews. The 
researcher and participant are not limited by the protocol. It is typical that data 
sets collected using unstructured interviews will be larger than the other two 
techniques.  
2.3.3 Secondary research 
Secondary research is gathering and reanalyzing data that have already been 
collected, this data is often referred to secondary data. Secondary data include 
both quantitative and qualitative data and they are used in both explorative, 
descriptive and explanatory research. 
2.4 Quality of results 
To ensure a good quality of a research are obtained, criteria such as reliability 
and validity should be evaluated.  
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2.4.1 Reliability 
Reliability is a measurement on how well a method will provide the same or 
almost the same results each time when iterated. It shows how much influence 
different factors have had on the research method. Reliability is often used when 
preforming a quantitative research showing how stable a measurement is.  
2.4.2 Validity 
According to Bryman and Bell validity is one of the most important research 
criteria’s. When performing a research it is central to be able to validate whether 
the conclusions that are generated are related or not. Validity is divided into 
intern- and extern validity. Where intern validity are the compliance between the 
researcher’s observations and the theoretical ideas developed. Extern validity is 
instead whether the results can be generalized and applied outside the studied 
population.  
2.4.3 Triangulation 
Triangulation is the use of two or more independent sources of data or data 
collection methods to analyze research findings within a study.  It is primarily 
associated with quantitative researches but can be used to increase reliability for 
qualitative studies. A combination of qualitative and quantitative methods are 
often used in order to control the validity of the results.  
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2.5 The selected method 
To ensure a good reliability different kind of methodologies where used to gather 
information for this master thesis. The thesis is based on information from 
literature- and desktop research, survey answers, interviews with key 
stakeholders, gathered information from attended global and local events. 
2.5.1 Secondary research 
To get an understanding of the field and where the knowledge base are a literature 
research where preformed. Information where gathered from different types of 
academically literature search databases like LUB, LOVISA and LIBRIS. When 
searching databases some of the keyword that were used where, eHealth, 
connected healthcare, mHealth and innovation. Reports and articles were also 
gathered from the European Commission.  
2.5.2 Survey 
The main goal of the survey was to gain knowledge and get a better 
understanding of the regional ecosystem. Using a survey made it possible to get 
answers and opinions from a large amount of people in a fast and economical 
way. Method for the analysis where an explanatory survey study. The choice of 
an explanatory strategy where determent upon the relative new business area 
digital healthcare and eHealth is considered to be and the lack of previous studies 
in the area. The survey was a part of “READi for Health” and the survey was 
performed in four different countries, with four different first languages. As this 
master thesis focus on Skåne the other regions will not be included. 
2.5.3 Interviews 
To verify trends and findings in the survey and from desktop research interviews 
were held with key stakeholders. The interviews method choice where semi-
structured interviews because of the ability to get answers on key question and 
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also capturing more subjective opinions and needs. Swedish examples of the 
guides that was used can be seen in Appendix 2-4. Different guides where used 
depending on the business area of the interviewee.  
2.5.4 Attended events 
In order to gather information on the current situation on a local-, national-, and 
global level events where attended. This to see what expert in the field where 
thinking and to capture upcoming global trends. Over the course of time a total 
of six different events and day seminars was attended. During the events notes 
on interesting seminars where gathered and unstructured interviews where held 
with seminar participants.  
• Hur ska då sjukvården lyckas öka sin produktivitet i en omfattning 
tillräcklig för att möta framtidens behov?, 13 Februari, Mats Olsson, 
Medeon Science Park 
• Medicinteknik i Skåne, Lund, 12 Mars 
• Vitalis 2014, Gothenburg, 8-11 April 
• Connect and be READi for Health, Lund, 24 April, Mats Ekstrand, 
Medicon Village 
• Strödstrukturer för innovation i Skåne, 20 Maj, Media Evolution City, 
Malmö 
• Digital Health Days 2014, Stockholm, 25-26 August  
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 Theoretical framework 
The theoretical framework chapter describes the theories and models used for the 
collection and analysis of the gathered empiric data. The theoretical framework, 
se figure 3, consist of two methods that can be used in combination to each other 
to map the region, PESTEL and SWOT. The third method is applying the TOWS 
framework on the findings in the previous steps to form suggested strategies. 
3.1 Innovation types 
Innovation refers to changes that can be categorized in different ways. This thesis 
will use a categorization called “the 4P´s of innovation”. When talking about 
innovations there will be product-, process-, position-, and paradigm innovations. 
The model was developed by John Bessant and Joe Tidd (2009) and they explains 
the different types like this: 
• Product innovation – changes to a product or services that already exist. 
A good example is the ball pen, changing the way a pen is delivering the 
ink to the paper. 
• Process innovation – changes in the ways a product or service are 
manufactured or delivered. It can be a changes and optimization in the 
underlying manufacturing process or new delivery systems like just-in-
time. 
• Position innovation – changes in the context, how a product or service is 
perceived and how it’s used. An example showing the power of re 
position is the glucose-based drink Lucozade developed for children and 
invalids in convalescence. The dink become associated with sickness and 
later abandoned. When it re-launched they positioned the product as a 
performances enhancing drink for athletes. Giving the drink a new image. 
• Paradigm innovation – changes in the underlying mental models which 
shape what an organization does. The most common known example is 
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Henry Ford who changed the car manufacturing industry. From being a 
product for wealthy few to become mass-produced for a price everyone 
could afford. 
 
3.2 Innovation degree 
When talking about innovation they can be classed into two groups, incremental 
and radical. An incremental innovation is often an improvement in the production 
cost or function of an already existing product on the market. Most innovation 
can be categorized into this field. A radical innovation on the other hand explores 
new technology and creates a change that transforms existing markets, industries 
or can even create new ones. 
Combining the 4P´s with the innovation degree gives the potential innovation 
space where an organization can operates within, see figure Figure 4.  
 
Figure 5 the Innovation Space 
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3.3 PESTEL 
PESTEL stands for Political, Economic, Social, Technical, Environmental and 
Legal. Johnson, Scholes, & Whittington describes it as a tool for assessing the 
external influences from the environment of a region, business or organization. 
A PESTEL analysis can be done alone or as a tool to provide context for example 
a SWOT. The tool can help to highlight environmental shifts and changes that 
might have been overseen if only a SWOT analysis would have been done. 
• Political – Laws, global issues, legislation and regulations which may 
have an effect a business either immediately or in the future. 
• Economic – Taxes, interest rates, inflation, the stock markets and 
consumer confidence all need to be taken into account. 
• Social – The changes in lifestyle and buying trends, media, major events, 
ethics, advertising and publicity factors. 
• Technological – Innovations, access to technology, licensing and patents, 
manufacturing, research funding, global communications. 
• Legal – Legislation which have been proposed and may come into effect 
and any passed legislation’s. 
• Environmental – Environmental issues either locally or globally and their 
social and political factors. 
 
3.4 SWOT 
SWOT stands for Strengths, Weaknesses, Opportunities, and Threats. It´s a tool 
developed in the 1960-1970 and used to evaluate projects, products, organization, 
places, or business ventures.  
• Strengths are characteristics of the business or project that give advantage 
over others. Strengths are internal positive factors 
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• Weaknesses are characteristics that place the organization or project at a 
disadvantage relative to others. Weakness are internal negative factors. 
• Opportunities elements that could exploit to its advantage. Opportunities 
is external positive factors 
• Threats external elements that could cause trouble for the business or 
project. Threats are external negative factors 
These are often gathered with the help of a matrix, see below, that’s why a SWOT 
analysis also might be known as a SWOT matrix. It is important to have in mind 
that a SWOT analyze is often drawing up a list of current company strengths, 
weaknesses, opportunities and threats. This leads to generating strategies based 
on the current situation. If a change is going to happen in the organization’s 
environment a strategy built on past situations is very likely to be badly suited to 
the upcoming changes. When actions built on the old SWOT is launched new 
strength, weaknesses, opportunities and threats will have arisen.  
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Figure 6 SWOT matrix 
 
3.5 TOWS 
It´s a tool for matching threats and opportunities with the weaknesses and 
strengths of a company or organization. The tool was created by Heinz Weihrich 
and it can be considered a variant of the SWOT analysis but it’s more focused on 
strategic planning. In order to use the tool preferably an SWOT analysis and a 
ranking of the most important factors should have been done beforehand. In 
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every quadrant of the TOWS matrix there will be a combination of internal and 
external factors. The goal is to consider how to use them to create a good strategic 
plan. There is some questions that are good to ask yourself when doing each 
quadrant of the matrix.  
• Strengths and Opportunities (SO) – How can you use your strengths to 
take advantage of these opportunities? 
• Strengths and Threats (ST) – How can you take advantage of your 
strengths to avoid real and potential threats? 
• Weaknesses and Opportunities (WO) – How can you use your 
opportunities to overcome the weaknesses you are experiencing? 
• Weaknesses and Threats (WT) – How can you minimize your weaknesses 
and avoid threats? 
 Strengths 
1. 
2. 
3. 
Weaknesses 
1. 
2. 
3 
Opportunities 
1. 
2. 
3. 
 
SO 
Strategies that use 
strengths to maximize 
opportunities. 
WO 
Strategies that minimize 
weaknesses by taking 
advantage of 
opportunities. 
 
Threats 
1. 
2. 
3. 
ST 
Strategies that use 
strengths to minimize 
threats. 
WT 
Strategies that minimize 
weaknesses and avoid 
threats. 
 
Figure 7 TOWS matrix 
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 Key areas of interest, Healthcare and ICT-
challenges 
This chapter have a short summary explaining the different key ICT areas that 
has been identified as important for innovation in healthcare. These are security, 
semantic interoperability, cloud computing, pre-commercial procurement and 
big data. 
4.1 Security, 
Information security is considered important means protecting information and 
information systems from unauthorized access, use, disclosure, disruption, 
modification, or destruction in order to provide: 
• Integrity – which means guarding against improper information 
modification or destruction, and includes ensuring information 
nonrepudiation and authenticity 
• Confidentiality – which means preserving authorized restrictions on 
access and disclosure, including means for protecting personal privacy 
and proprietary information 
• Availability – which means ensuring timely and reliable access to and use 
of information. 
In Sweden there is “Patientdatalagen” (2008:355) and Patientdataförordningen 
(2008:360) which regulates the use of personal information and EMR.  
4.2 Semantic interoperability 
Semantic Interoperability ensuring that the precise meaning of exchanged 
information is understandable by any other application that was not initially 
developed for this purpose. Thus, enables systems to combine received 
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information with other information resources and to process it in a meaningful 
manner. Semantic interoperability is the highest level of interoperability followed 
by structural and foundational. 
4.3 Cloud Computing 
Cloud computing is a model for enabling on-demand network access to a shared 
pool of configurable computing resources (e.g. networks, servers, storage, 
applications, and services). The service is flexible and can be increased or 
decreased rapidly with minimal management effort or interaction from the 
service provider. Cloud computing makes it easier and affordable for start-ups to 
acquirer computer systems and computing power compared to traditional on-site 
IT resources. With the benefit of being scalable with the growth of the company. 
4.4 Pre-commercial procurement 
Pre-Commercial Procurement (PCP) refers to the public procurement of research 
and development on new innovative solutions before they are commercially 
available. PCP works in conjunction with Public Procurement of Innovative 
Solutions (PPI). 
In some cases, public sector challenges can be addressed by innovative solutions 
that are nearly or already in small quantity on the market and don't need new 
research and development (R&D). This is when Public Procurement of 
Innovative solutions (PPI) can be used effectively. 
PCP and PPI makes it possible to develop a forward-looking innovation 
procurement strategy driven by demands and needs. This enables the public 
sector to modernize public services faster and drive innovation forward. 
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This procurement tool is meant to promote innovation through: 
• a competitive research and development process, 
• a risk sharing strategy between the bidders and the procurer, 
• a buying process,  
4.5 Big Data 
Big data often refers to unstructured data that are too big to fit on a single server. 
The amount of data that’s generated today is enormous. For instance the average 
company has 427 times the amount of data that ever recorded in the Library of 
Congress. The volume, unstructured form and constant flow of new information 
makes it hard to use tradition analysis methods, resulting in the use of machine 
learning.  
Healthcare is considered one of the emerging markets for the use of big data. The 
EMR are getting more structured and with the help of natural language 
processing technologies physician’s and nurse’s notes can be captured and 
classified. The beliefs are that if all data could be integrated, categorized and then 
analyzed we´d know a lot more about the patient conditions with the help of 
information we already have. With eHealth, tele-medicine, mHealth and all 
connected devices there will be massive amount of data that will be generated. 
The big challenge is not to gather big data, it´s how to use this vast amount of 
information.  
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  Background analysis of the Skåne region and 
healthcare 
This chapter will present the current situation of Skåne and where it´s heading. It 
consist of a summary of the population growth, the regions vision, industries and 
market analysis. 
5.1 Skåne  
Skåne is located in the southern parts of Sweden and 2012/2013 consisted of a 
population of 1 263 088. By the year 2022 the population is expected to rise to 
1 369 000 people, which is an increase of 8.4%. The population in the region is 
increasing at a faster rate than the nation as a whole. This is the result mainly 
because of the migration to Skåne from other provinces have been greater than 
the emigration. The rising population will put higher demands on the 
infrastructure of the region, including the healthcare system. Michael E Porter 
and Elizabeth Olmsted Teisberg mean that today’s healthcare system is delivered 
with a 1800s organization. These thesis is backed up by professor Regina E. 
Herzlinger who says “Yes, medical treatment has made astonishing advances 
over the years. But the packaging and delivery of that treatment are often 
inefficient, ineffective, and consumer unfriendly.” The Swedish social minister 
Göran Hägglund want to reform our 150 years old healthcare organization. It 
comes clear that current healthcare systems are building on old organizational 
structure. 
Skåne has a vision to be Europe´s most innovative region 2020. The foundation 
of the strategy is substantial investment in reinforcing Skåne’s innovation culture 
and capacity. According to the strategy a culture which grows out of the creativity, 
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openness and diversity that Skåne has today. When looking at Sweden as a whole 
country it is considered one of the innovation leaders in the European Union. On 
eHealth solution implementation Sweden gets ranked 3rd in Europe, beaten by 
Estonia and Denmark.   
There is a strong business sector and market in Skåne. Big global mobile industry 
companies have ongoing research and/or development activities, such as 
Ericsson, ST Ericsson, Sony, Qualcomm, and TeliaSonera to name a few. There 
is also a lot of other high-tech ICT companies located in the region like SICS 
Security who has located a research team in the region. This resulting in strong 
research in key areas like, ICT (Security, cloud computing, mobile, gamification, 
Internet of Things, data analysis, sensor, camera) as well as biomedical 
engineering, life science and medicine.  
World leading international research facilities in material science are being built, 
Max IV and ESS (European Spallation Source). These will not only strengthen 
the regions research capability’s but also the attractiveness of the region. There 
is hopes that the facilities will have spin-off effects that might generate job 
opportunities and increase the economic growth for the region. 
The region has a strong platform for higher education. Skåne has world class 
research institutions combined with four universities making it one of Europe´s 
leading educational and scientific centers. University of Lund, founded in 1666, 
is Scandinavia’s largest campus for research and higher education. It´s ranked as 
one of the top Universities in northern Europe. Malmö University is one of 
Sweden´s newest higher education institutions and it´s growing rapidly. 
Kristianstad University is a smaller institution specializing in among other things 
health sciences and engineering. The fourth is the Swedish University of 
Agricultural Sciences with its main campus in Alnarp. 
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When combining Skåne with the Øresund Region which includes Greater 
Copenhagen, a total number of over 135,000 students, 12 universities and 10,000 
scientists is located in the area. The region is housing scientific networks like the 
Medicon Valley Alliance, Øresund IT, Øresund Food and Øresund Environment. 
The region has one of Sweden’s oldest hospitals, the infirmary in Lund 
established 1768. To enhance the competitiveness of the region the 1 January 
2010 the University hospitals in Malmö and Lund merged to one collective 
University hospital. The goal was to enhance the service in a Swedish and an 
international context, to enhance the scope of clinical research and to enhance 
the hospital's attractiveness as a workplace.  
In 2013 Sony Mobile Communication, Region Skåne and Lund University 
founded MAPCI (Mobile and Pervasive Computing Institute at Lund University). 
MAPCI is a research institute that focus on distributed cloud technology. One of 
the main goal is to take on the role of a bridge-builder between existing mobile 
research center in southern Sweden and the industry.  
5.2 Market analysis 
The healthcare system in Sweden are to most extend government funded with 
taxes. It’s decentralized into 21 regions and county councils. The result of this 
decentralization are that the healthcare market in Sweden becomes fragmented 
with every independent region and county council. Looking at the domestic 
market of region Skåne it´s considered quite small with its 1 million citizens.  
To try and cope with the small market Region Skåne have started to collaborate 
with the two other big regions in Sweden, Region Stockholm and Region Västra 
Götaland. Making them together a bigger player and bigger potential market.  
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 Figure 8 Global mHealth market revenue in USD (2013-2017) 
Because of the relative small domestic market in Sweden it´s important to take a 
look globally. The global eHealth market is forecast to grow tremendous over the 
upcoming years. Report forecast the global teleHealth market to grow from 7.6 
to 17.6 billion Euros already by 2017. Another report shows that only taking the 
global mHealth app market to account it´s revenue will reach USD 26 billion by 
2017. That number would be equal to a 0.5% share of the global healthcare 
market. It´s still an uncertain how much the market will grow in the future but 
everyone are agreeing that the market is still in an early phase. 
Region Skåne can benefit from this growing market segment. A strong 
innovation, adaptation and exportation can give a better quality of life for citizens, 
growth for the industry and tools for managing the upcoming demands on the 
healthcare system. Innovation in ICT can provide with better and cheaper 
healthcare services. One estimations done for the European Commission shows 
that the introduction of better ICT and telemedicine alone might improve 
efficiency of healthcare by 20%.  
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5.3 The innovation support structure in Skåne 
A recently released report performed by CIRCLE (Centre for Innovation, 
Research and Competence in the Learning Economy, Lund University) shows 
that the innovation support structure is fragmented. The innovation support 
structure in Skåne is consisting of 93 different actors. Of them 53 have some 
specific sectorial focus and 60 of them are working regionally. The diversity 
among the organizations are good but some areas are still missing. 
Geographically most enterprises are established in southwest part of Skåne. A lot 
of them have some sort of connection to the different Universities in the region, 
Lund’s University, Swedish University of Agricultural Sciences and Malmö 
University all have some organization linked to them.  
There has been a debate around the number of actors and the question if they are 
too many or too few. People are not unanimous on the issue and they have not 
come to any consensus in the matter. It´s clear that entrepreneur’s might have a 
hard time knowing where to go but on the other hand the new organizations’ that 
have started are filling gaps and missing areas. 
There is already established collaborations between some of the bigger 
organizations. Networking between the innovations support structures in Skåne 
have come up on the agenda. Region Skåne has taken an active role and started 
to invite to seminars and discussion meetings. The idea is to promote 
collaboration and create a shared vision for the region. This is a way of 
overcoming the fragmented structure and make it easier for people to seek 
support. The long term agenda is to get Skåne known outside the region as a good 
place for new entrepreneurs.  
These goals are embedded in International Innovation strategy for Skåne. The 
strategy highlights personal health as one of the great potential innovation areas 
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for the future. Points on the importance of partnerships between various clusters 
as essential for inventiveness and innovation in the region.  
Today’s innovation system is focused on the early phases. Continued financing 
for the later growth phase is harder to get which entrepreneurs can attests to.  
The innovation strategy also push public‐sector players such Region Skåne and 
Skåne municipalities to support the development of system innovations through 
PCP and PPI. 
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 Upcoming global trends in healthcare 
This chapter describes upcoming global trends in healthcare. These trends will 
affect how healthcare is going to be delivered both on a local and global level. 
Therefore is it important to have upcoming trends in mind when looking at new 
innovations, products and delivery systems.  
6.1 Value-based healthcare  
In the new area of healthcare the patient must be in the center.  The flow should 
follow the patient horizontally through the organization. Today's management is 
based largely on the producer's performance in the form of, capitation, visits, 
hospital days, and operations. Any improvement of the organization is therefore 
often performed on unit level and their unit’s perspective. The result is vertical 
silos where the patient flow is left out of the picture. People in systems of care 
are aware of these problems and have given it its own name: NAP (någon annan 
patient), which is read someone else's patient. 
Peter Lindgren raises, in the report ”Ersättning i sjukvården modeller, effekter, 
rekomendationer”, the need to evaluate different compensation system. Sweden 
has a unique opportunity to study the effects of reforms of our remuneration 
model. Central data warehouse and systems makes it possible for many county 
councils have a good overview of their healthcare system. Combined with both 
national records and quality registers makes a good foundations to evaluate 
different models with relevant control groups. 
Work is being done in this area, a joint study is being performed by KI, Swedish 
Hip Arthroplasty Register and Harvard Business School. Results from this study 
shows better coordination of the care chain, 17% increased operational 
productivity, higher focus on health outcomes and avoiding complications, 98% 
satisfied patients and no waiting. It’s important to follow what comes out from 
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this study as it might change the way healthcare is going to be performed and 
compensated in the future.  
6.2 The enlightened patient 
Patients are acquiring more and more knowledge about their disease and 
symptoms. This results that doctors and physicians are engaging with a more 
enlightened patient, a patient knowing more which requires a different approach 
than before.  
One of the most known enlightened patients are e-Patient Dave de Bronkart. How 
he by doing his own research survived a grade 4 kidney cancer which were 
diagnosed at a very late stage. The doctors gave him a median survival time at 
just 24 weeks, he had tumors in both lungs, several bones, and muscle tissue. 
Going online and searching for other patients who have survived similar 
conditions he found which treatments he should use and how he should prepare 
himself before going into them. As he said at a seminar on “Digital Health days 
2014 in Stockholm” quoting Donald Lindberg, director of the National Library 
of Medicine. 
“If I read and memorized two medical journal articles every night, by the end of 
a year I’d be 400 years behind.” 
Nowadays a single person or doctor can’t know it all, there is a new age of 
information. Doctors will have a different role in the future. 
6.3 Patient groups 
An increasing numbers of patients have begun to organize themselves into 
different patient groups, pressure groups, self-help groups and Internet 
communities. This is a result of the increasing patient power and individual’s 
choosing to take a more active role in the healthcare system. People think about 
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the healthcare like they think about other services. It´s a rising demand to be 
informed and involved. Gathering in groups helps them to get more knowledge 
about their specific disease and helps them to be more equal with the doctors and 
the system.  
One of the most known patients groups is PatientsLikeMe where patients can 
share their experience, give and get support to improve their life and the lives of 
others. It also works as a patient powered research network and a real-time 
research platform to help make advances in medicine. 
6.4 Sharing data 
People and patients are getting opened minded of sharing their personal data. A 
survey of 2,125 PatientsLikeMe members in the U.S. says that they are opened 
to the idea of sharing their health data online if it helps clinicians improve care, 
helps other patients, or advances medical research. Another survey done by 
Makovsky Health/Kelton shows that 90% would share their data as long as it was 
anonymous. 
Another trend that has been started in the last year is companies giving away data 
from clinical trials to the academia for further research. Johnson & Johnson is 
one of the first who has decided to give all the data from their pharmaceutical 
clinical trials to researchers at Yale University. It is a part the Yale University 
Open Data Access (YODA) project and they are also giving anonymized patient 
data from its pharmaceutical arm Janssen. The data is not just for the Yale 
University, other researcher who request it will get access to the data. 
In Europe the members of the European Parliament have voted in favor 
introducing legal measures to increase the transparency of clinical trials in 
Europe. The law will force all trials to be registered on a publicly accessible EU 
clinical trials register before they can begin. Within a year after the trial ends a 
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summary of the trial results is required to be posted along with a lay summary 
for the general public.  
This is a good start but can be compared with a similar law made by the United 
States in 2007, the FDA Amendment Act. Like the European it requires all trials 
conducted in the United States to be registered and summary results to be 
published on a national publicly accessible register, clinicaltrials.gov, within a 
year of trial completion. An audit of clinical trials made in 2012 showed that 
almost 80% failed to publish their results within a year after completion. 
Hopefully the European companies will perform better than the American 
counterparts, the law should be considered a step in the right direction. 
6.5 Standards 
Standards is a part of the second level of interoperability, Structural. In healthcare, 
standards provide a common language and defines the syntax of the data 
exchange to enable interoperability between systems. In order to improve 
healthcare delivery data should be able to get shared between clinician, lab, 
hospital, pharmacy, and patient regardless of application or application vendor. 
 
To improving interoperability various platforms have been started on a global 
level such as Continua, HL7, IHE Europe, epSOS, the study on the eHealth 
Interoperability Framework, the eHealth Governance Initiative, the 
establishment of the eHealth Network6. 
A report made by eHealth Stakeholder Group on Perspectives and 
Recommendations on Interoperability launched in March 2014 shows that 
several local eHealth actors are not well informed about the interoperability 
initiatives that’s going on and instead tend to build local isolated eHealth 
programs.   
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6.6 mHealth application 
Most stakeholders agree that mHealth application will have a great impact on the 
healthcare during the upcoming years. It will improve patient outcome, 
prevention and help people and patient to take better care of their own health. A 
study released in May 2014 shows that mHealth applications will have the 
biggest impact areas to reduce non-compliance and hospital readmission costs. 
Smartphones and tablets penetration combined with user and patient demand are 
considered be the main drivers for mHealth uptake. The biggest barriers mHealth 
app developers see is to overcome is the lack of data security and lack of 
standards.  
Comparing two reports regulation is consider a barrier but one report points it as 
a main market barrier during the commercialization phase and the other only puts 
it as a hygiene factor. Other interesting facts are that clinical requirements and 
clinical studies are ranked as low hygiene factors. These are in traditional 
healthcare ranked as important factors. Clinical requirements and studies might 
not be the first thing a mHealth developer thinks about but should be considered 
important if the application will deliver any form of advice or guidance to the 
consumer.  
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 Summary of data 
The empiric chapter presents the gathered research data from the depth 
interviews and survey results. In the later part of the section all the gathered data 
including an earlier PESTEL analyze are represented in the SWOT analyze of 
the region. 
7.1 Interviews 
The focus on the interviews where on key stakeholders in the triple helix structure 
and to improve areas where there was lacking survey responses. Like the survey 
many people were having different roles and cross sector responsibilities. There 
where private healthcare provider who both can be put into healthcare and 
business sector as an entrepreneur. Professor from the academia who were 
pursuing new business. PhD student who both work in the healthcare sector and 
with academic research. From the business sector there was a good spread of 
companies, from big commercial mobile technologies, large ICT, smaller data 
analysis to one man private healthcare provider. From the innovation resources 
and infrastructure and policy makers one from each sector got interviewed. In 
total nine interviews where preformed taking from 1 to 1,5h each.  
7.1.1 Results from the interviews  
From the interviews it comes clear that Region Skåne perceived as a fractured 
organization. People from academia, healthcare and business point out the 
difficulties to find who to talk to and where to go in different matters.  
Three of the respondents have pointed out that it´s hard to be informed on what’s 
going on in the region. It´s hard to find information of events, discussion 
meetings and seminars concerning digital healthcare, eHealth and other topics. 
They are missing a support structure and a place to find information on upcoming 
activities.  
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When it comes to innovations a respondent from the business sector thinks that 
the right way to go forwards is to make small pilot or test units working close to 
the profession. The strengths of this approach is to have a short life cycle, 
constantly feedback from the end users and iterate. Looking over the ocean at 
Silicon Valley their constant innovation is a result of generations of product 
iterations and failures. The idea is to show a proof of concept, showing what the 
new technologies are capable of doing. In a later state using this to tear down 
perceived barriers and take the innovation into the healthcare system.  
It is important to have a well-structured system after a project, hackathon or 
brainstorming meeting. There must be a system to facilitate the projects after they 
are done or the new ideas that comes up. When using hackathons or 
brainstorming sessions both the healthcare and business sector pointed out the 
importance of narrow it down to targeted areas and involving a good mix of 
expertise from all sectors. The participants is of the utmost importance to get a 
great innovation process.  
Most of the interviewed people raised the triple helix structure and mobile 
industry as strengths for the region. However one of the respondents are critical 
to why companies should be located in Skåne. The opinion was that there is at 
least 20 or more locations worldwide that have the same or better conditions as 
Skåne. “There is nothing that unique which could insist companies to move here.” 
Issues highlighted was the integrity issue combined with regulatory demands, 
personal data and privacy protection. These are a challenge and considered 
barriers for innovation in digital healthcare in the region. Over the years 
regulations and laws has become more and more complex and the cost have gone 
up. There is a need for it to be simpler, easier and cheaper to do product 
development for healthcare applications.  
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The remuneration systems is lifted up as one of the biggest barrier for innovation 
and new investments. In Sweden the health clinics remuneration system is based 
on payment per treatment (tariffs) and a fixed remuneration (capitation). The 
existing remuneration model doesn’t reward progress in quality or preventive 
care. This resulting in local process improvements and investment which in some 
cases doesn’t improve the system as a whole. The IT investments are risking to 
be optimized for the specific clinic and not for a horizontal patient value chain.  
One of the interviews responded that the innovation system is fragmented. The 
feel is that there are many who talk about innovation but no one is doing anything 
concrete. There is a need to be more focused and have more targeted investments 
in digital healthcare to succeed. It’s hard to get money for the early phases of 
development and especially when try to go into the growth phase. Advice is easy 
to get but it is difficult to draw in any money.  
Higher education institutions do not have access to training in electronic medical 
record. Doctors and nurses are expected to be trained during their practice from 
their supervisor. Thus, their training will be depending on their supervisor's 
expertise and time. It is common that care professional are not fully trained in 
what EMR can perform. There is a tendency to facilitate the insertion into the 
journal by skipping parameters. This is due to a complicated system but allows 
new nurses to learn bad practices from the beginning. Instead by having courses 
in EMR there is time to show what EMR´s are capable of and pushing for the 
importance of insert all parameters for future records. New doctors and nurses 
would have a better foundation when starting to practice in the hospitals and they 
can raise the competence of the profession from below. 
7.2 Response rate from the survey 
In Skåne a total number of 1514 surveys where sent out by email to different 
stakeholders and business sectors. Of them 435 completed the full survey 
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making it a response rate of 29%. Taking into account that the survey where 
sent out by email to individuals who didn’t have any relations with the project 
the response rate can be considered good. The spread between businesses 
sectors can be seen below.  
Table 1 Response rate per business sector 
Business sector Skåne 
1. Politician or policy maker 58 
2. Academic research 22 
3. Business 60 
4. Healthcare  241 
5. Patient organizations/foundations 20 
6. Wellness organizations 3 
7. Innovation resources/infrastructure 27 
8. Funding or investments 4 
 
The respondents were free to choose what business sector they represented. 
Analyzing the survey it come clear that many persons who we initial thought 
represented one sector have chosen to identify themselves as another. This 
making it hard to perform any analysis of sectorial response rate.  
7.2.1 Politician or policy makers 
The response rate from politician and policy makers can be considered 
representative for the region. There is a broad spread of responsibility among the 
politicians and policy makers that answered the survey. This indicates that the 
intentions with a wide distribution of the survey is fulfilled. Among the 
responders there is representatives from 15 of Skånes 33 municipalities. The 
spread is from the large down to small municipalities. Looking from a political 
point of view almost all parliamentary parties have at least one representative that 
answered the questioner. There is 28 from the region council and also 
representatives from the association of municipalities. 
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 7.2.2 Academic research 
Most of the people from academia that we have got in contact with are from 
Lund’s University. Looking at the respondents there is a mixture of faculty’s 
from LTH (The Faculty of Engineering at Lund University) and Faculty of 
Medicine. There is no respondents from faculty of economics, law or natural 
science. From LTH there is a mixture of biomedical- , electronic engineers, 
design and computer science. The largest part of participants are biomedical 
engineers. 
This explains the strong expertise in biomedical engineering, life science, 
eHealth and analytic and sensor technology. These are areas where Skåne have a 
long tradition of research. Most respondents have at least answered that they have 
three of more expertise which shows that they are multidisciplinary. However, 
there is no expertise in semantic interoperability among the responders in Skåne.  
7.2.3 Business sector 
From the business sector there is 53 unique companies’ represented. They are 
ranging from small start-ups to big multinational cooperation’s. About 30% of 
respondents represent entrepreneurs, small companies and big companies 
respectively. However, only 8% of the respondents represent medium size 
companies. In Sweden 99.4% of all companies consist of entrepreneurs and small 
companies with fewer than 50 employees. 
7.2.4 Healthcare  
In the healthcare sector there is an additional 10 unique municipalities that 
answered, giving a total number of 25. There is also some representatives from 
the association of municipalities that have considered them as healthcare. 
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A large group are from Skåne University Hospital and Region Skåne. However, 
a lot of the responders are from smaller organizations and municipalities.   
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7.3 Survey results 
The unawareness of standards is confirmed by the survey handed out in Skåne.  
It´s clear that the business, see Figure 18, and academia, see Figure 19, are not 
aware or not using medical terminologies and standards. 
The United States and United Kingdom has started to collaborate around the use 
and sharing of health IT information and tools. The agreement strengthens efforts 
to cultivate and increase the use of health IT tools and information designed to 
help improve the quality and efficiency of the delivery of healthcare in both 
countries.  
One part of the collaboration is around interoperability standards for 
improvement of data sharing and clinical care. There is also a focus on patients 
accessing and sharing their data. Thus, it´s important for small countries like 
Sweden to monitor this collaboration and its outcome.  
Looking at the healthcare sector and splitting it in public and private sector some 
differences shows. The private sector are using mobile e-tools to a lot higher 
degree then paper-based tools, see Figure 21. In the public sector it´s the other 
way around. If the question is crossed with “Our responsibility is…” you get an 
interesting result, see Figure 20. Tertiary and secondary care, which accounts for 
the largest part responders, both have relative low score on the use of mobile e-
tools compared to other sectors. 
The healthcare sector they ranked “Difficult to find time to elaborate ideas in 
parallel to regular assignments” as the single major difficulty/barrier for creating 
innovations based on ideas from their profession, see Figure 22. The healthcare 
sector has already a high workload so it might be hard to implement free time to 
pursue own ideas like great innovative companies are doing, such as 3M, W L 
Gore or like Google used to do with their now abandon 20% time rule. There is 
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also the question if healthcare professionals is the right people to pursues and 
evolve their ideas, partnership with other actors might be more suited.  
Looking at the collaborations for both business and the academia both have a 
relative low collaboration with Interest groups (e.g. customer focus groups, 
patient organizations), see Figure 23 and Figure 24. Business thinks that 
partnership is the most important factor for them to develop innovative products. 
It´s along with healthcare expertise the biggest challenge to create innovations in 
digital healthcare, see Figure 25. Not a single person from the academia have 
answered that partnership with costumers are among the most important factors, 
see Figure 26. The respondents where only allowed to check three alternatives 
which might be the reason. Long term funding for research getting 100%. The 
biggest challenge for academia is to get hold of healthcare expertise followed by 
knowledge of customers need. There is a demand for access to healthcare 
expertise and customer knowledge from both the business sector and academia. 
Here is an opportunity to facilitate partnership and exchange of experience and 
knowledge among stakeholders, physicians, healthcare experts and customers. 
This to help entrepreneurs to get hold of real needs. According to Alan Cooper, 
modern user experience design expert, the ideal approach for innovation is “goal 
directed.” Innovation should start with the needs and goals of the customer or 
end-user. How the problem should be solved and the solution for it comes next.   
“Technology is worth nothing if it doesn’t solve an important problem or improve 
lives.” Robert Pearl, M.D., CEO of the Permanente Medical Group  
All business sector has answered almost identical on the question “In our opinion, 
eHealth research should be more… (multiple answers allowed)”. It’s clear that 
they think that research should be more interdisciplinary (involving several 
stakeholders in the ecosystem). This reinforces the importance of cross boarder 
meetings and relations to get a good climate for innovation.  
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7.4 PESTEL 
7.4.1 Gather the information 
Information for the PESTEL analysis was based data from READi for Health 
survey, interviews, events and desktop research. 
Political 
• Patient centred point of view from politicians 
• Willingness to support and lower barriers for PCP  
• National eHealth agenda lack global view 
• Stockholm´s lack of interest in the region  
• Not a capital city (distance to government, lack of funding, harder to 
recruit personnel and competence)  
Economic 
• Hard to get access to financial capital in the growth phase 
• Unclear business models for eHealth solutions 
• 20 different regional councils in SE with responsibility in healthcare, 
which  results in a fragmented market, difficulties to reach common 
standards and IT/IS infrastructure  
Social 
• Consumers – early adopters (ICT) and buying power  
• Openness and willingness to collaborate between companies and sectors.  
• Understanding for collaboration driven innovation. 
• Good language skills 
• A decreasing proportion of working age population  
• Shortage of engineers and healthcare professionals  
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• Engaged and knowledgeable patient / citizens 
• Strong social safety net 
Technological 
• Key area expertise, sensor, mobile, camera, design, Life science  
• Expertise in semantic interoperability is not available 
Legal  
• Data protection laws, hard to get access to health data 
• Costly to get access to health data  
• Legal requirements for security and protection of personal data 
 
7.5 SWOT 
7.5.1 Gather the information 
Information for the SWOT analysis was based on the PESTEL and complimented 
with data from READi for Health survey, interviews, events and desktop research. 
In the stage of analyzing the survey a plan was structured to make sure the 
analyses of questionnaire responses where done consistently and in a way that 
works as a good input for the thesis, see Appendix 1. This to ensure the capture 
of information that were relative to the SWOT analysis. Depending on what 
category the information was considered to be it got labelled with one or a 
combination of the following S, W, O, T letters representing Strength, Weakness, 
Opportunities and Threats. New information that come from the semi-structured 
interviews, events and the desktop research where then added. For region Skåne 
this list consisted of a vast amount of information and entries.  
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7.5.2 Sort information 
The most important step is to sort the information into the different categories, 
strength, weakness, opportunities and threats. When doing this it’s important to 
keep in mind what is an external and internal factor. During the first gathering 
phase and labelling it’s easy to mislabel an element. When working in teams it´s 
important to try and get a common understanding of what the different categories, 
external and internal factors really means. This shows the importance of a good 
theoretical framework to commonly work along as a team.  
7.5.3 Classify the information 
To get an easier overview of each category the elements where classified into 
different subcategories. Those where built upon the different business groups 
and what sector the element affects. The focus was on triple helix and 
healthcare. It was necessary to introduction a more a general subcategory for 
some elements.  
7.5.4 Validate the SWOT 
The SWOT analysis where discussed with the READi for Health team at Region 
Skåne and the project manager at Mobile Heights. To verify, get second opinions 
and inputs to the result it was also show to a couple of key ICT business actors 
and stakeholders at SUS. With the input and verification from the stakeholders 
the result of the SWOT analysis gives a good picture of the region. The list is not 
ranked at this stage.  
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 Strengths (part 1) 
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GENERAL 
• Triple Helix 
• One of Northern Europe’s top universities, Lund University 
• Geographical location, Øresund Region 
• Sweden as a brand (credibility) 
• Strong social safety net 
• Safe society conditions for social innovations 
• Access to science parks, incubators, test beds, clusters, IT-infrastructure 
• Business and innovations support for both life science and ICT 
• A long tradition in successful export/internationalization 
• Consumers - early adopters (ICT) and buying power 
• Openness, willingness and strong experience in collaboration between companies and 
sectors (with established silos) 
• Understanding for collaboration driven innovation 
 
POLITICIAN AND POLICY MAKERS 
• Patient centered point of view from politicians (including patient safety and service) 
• EHealth considered to be a driver for improvement of healthcare 
• Willingness to support and lower barriers for PCP 
 
HUMAN CAPITAL 
• Key areas expertise ICT, Life science and MedTech 
• Language skills 
• International experience 
• Experienced leaders in ICT and Life Science 
 
BUSINESS 
• Companies are born global 
• Big multinational ICT companies 
• Decent number of solid SME's 
• Strong experience in standardization from telecom industry - global networks 
• Proved capacity in commercializing and industrializing complex system solutions 
(connected system solutions) for a global market 
• Strong business in key areas, MedTech, life science, ICT (mobile, security, gamification, 
cloud, loT, data analysis, wearable’s, camera) and sensors 
• Mobile business with experience in whole value chain (hardware, software, design, etc.) 
• International collaborations 
• Design expertise UI/UX /user interface - user experience) in world class. Design 
companies able to build quick prototypes in iterative development processes.  
• Connectivity expertise 
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 Strengths (part 2) 
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ACADEMIA 
• Department of Biomedical Engineering (including eHealth track) 
• Full spectrum of faculties available in Skåne 
• Strong research in key areas, biomedical engineering, life science, ICT (cloud, mobile, 
security, gamification, loT, data analysis, camera), eHealth, medicine and sensor 
• SICS Security research team located in Skåne 
• MAPCI (Mobile and Pervasive Computing Institute)-Cloud and security aspects 
• World leading international research facilities in material science; Max IV and ESS 
(European Spallation Source) 
 
HEALTH CARE 
• Computer-based tools are standard in healthcare 
• Health care professionals with great interest and ideas in eHealth 
• Patient centered point of view (including patient safety and service) 
• Co-location of Universities and Skåne University Hospital 
• Secondary and tertiary care in addition to primary and home care 
 
PATIENT / PATIENT ORGANISATIONS 
• EHealth considered to be a driver for improvement of healthcare 
• Larger number of active patient / relative organizations established in Skåne (from rare 
diseases to chronic disorders) 
• Engaged and knowledgeable patient / citizens 
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  Weaknesses (part 1) 
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GENERAL 
• Unclear business models for eHealth solutions 
• Live and laurels (societal attitude) 
• PCP and innovation procurement is not well known or used 
• The innovation support structures is fragmented and there is no common picture of the 
business environment 
• Lack of focus on customer/marketing within innovation support structure 
• Working in silos 
• Region of Skåne perceived as a fractured organization making communication difficult 
• Internal and external branding of Skåne and Øresund 
• More competition than collaborations between actors 
• Cloud technology not implemented - Health care in Sweden has not embraced the 
opportunities with cloud technology (data protection laws) 
• Few projects where all competences are used 
• Lack of funding opportunities 
POLITICIAN AND POLICY MAKERS 
• Lack of long term vision and strategy for eHealth 
• Lack of available PCP policy 
• Hard to find regional policies and strategies and lack of version control 
• Lack of resources to handle innovative procurement processes 
• Lack of implementation strategy and processes for pilot projects 
HUMAN CAPITAL 
• Low awareness about healthcare standards and certifications (e.g. CE) 
• Low general knowledge about cloud 
INNOVATION SUPPORT 
• Life science -  Not as focused in internationalizations the ICT sector 
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 Weaknesses (part 2) 
In
te
rn
al
 fa
ct
or
s 
BUSINESS 
• Poor collaborations with interest groups 
• Difficult to access healthcare expertise, test beds and knowledge of customers' needs 
• Low utilization of innovation support 
• Lack of capital for expansion (seed money) 
• Lack of competence/expertise at VC companies with eHealth 
• Lack of expertise in semantic interoperability and interoperability 
ACADEMIC / RESEARCH 
• Academics lack of focus on access to market and internationalization 
• Academics have a low collaboration with public bodies and interest groups 
• Lack of expertise in semantic interoperability and interoperability 
• Little training in health informatics included in education program for health care 
professionals 
HEALTH CARE 
• Lack of global view for healthcare solutions 
• Old-fashioned IS/IT infrastructure and EHR-system, does not promote efficient use of 
knowledge and resources and negative effects an patient safety 
• Clinical information system lack interoperability 
• Complex healthcare organizations 
• Strong hierarchy in healthcare reduce flexibility and openness 
• Healthcare suffers from constant reorganization 
• Healthcare professionals do not have time, motivation and knowledge to elaborate 
their ideas 
• Lack of innovation strategy 
• Bad experience in current IT systems tend to make people negative to IT solutions 
• Clinics have their own budgets and makes their own priorities 
• Slow or no uptake/use of global standards (e.g. IHE and Continua) 
PATIENT AND PATIENT ORGANISATION 
• Patients nor comfortable to share their innovative ideas, proposals and data with their 
care givers (share with patient organizations/ communities, family and friends) 
• Public procurement does not include requirements global standards (e.g. Continua) 
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 Opportunities 
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GENERAL 
• The global eHealth market is forecasted to grow 
• Structured gathering of healthcare data (e.g. bio banks, quality registers) 
• International networks (e.g. ECHAlliance) 
• Horizon 2020 and other project funding programs 
• Product differentiation. MedTech (home, primary care, secondary/tertiary care) 
• Cost for health care: reconsider health care products and consumer products 
• Accelerators for scale of both public and private business 
 
HUMAN CAPITAL 
• Demand for ICT and Life Science expertise is increasing 
• Local access to ICT experienced citizens (early adopters of technology) 
 
POLITICIANS AND POLICY MAKERS 
• Flexibility in reimbursement model 
 
BUSINESS 
• Global market 
• Lifestyle and preventive care trend 
• New business models (definition of business models for eHealth) 
 
HEALTH CARE 
• Access to global specialized healthcare / expertise that is not available in the region  
• Rising demand on the healthcare system 
 
PATIENT AND PATIENT ORGANISATION 
• Access to global patient communities 
• Willingness and interest to contribute to eHealth innovation for improvement of care 
• Openness to new technology and care models 
• Empowerment of patients and citizens, will be a driving force for the development and 
implementation of eHealth 
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  Threats (part 1) 
Ex
te
rn
al
 fa
ct
or
s 
 
GENERAL 
• Security & integrity issues 
• Not a capital city (distance to government, lack of funding, harder to recruit personnel 
and competence) 
• Stockholm's lack of interest in the region 
• Risks and benefits of eHealth not equally highlighted in media (negative aspects 
dominates) 
• Insecure stability of SME's over time (healthcare requires stability when procuring 
new technology) 
• Old-fashioned way of thinking "free and equal care" creates barriers for testing and 
implantation of new solutions (limiting patients to pay for healthcare) 
• Initial up take of wrong / low quality products and services may result in resistance 
and in lack or trust in eHealth 
• 20 different regional councils and 300 municipalities in SE with responsibility in 
healthcare, which results in a fragmented market, difficult to reach common standards 
and IT/IS infrastructure, and inefficient use of public resources 
• Lagging behind the key players in Europe 
• Interpretation of legislation for security and protection of personal data 
 
POLITICIAN AND POLICY MAKERS 
• Government changes on national and regional level prevents long term strategic 
change management and implementation of eHealth 
• Lack of clarity regarding regulations for eHealth solutions 
 
HUMAN CAPITAL 
• Loss of competence within key areas 
• Slow moving labor market, people tend to stay at their jobs 
 
BUSINESS 
• Closure/relocation of key companies 
• Too long time to market for eHealth solutions and unclear regulations results in 
business avoiding healthcare market in favor for other less regulated markets 
• Healthcare unattractive sector for tech companies due to fear for bad will in case of 
adverse events 
• Too complex business model (buyers, payers, innovators, developers, customers – 
who will pay for it?) 
• Hard to get access to health data (data protection laws) 
• Costly to get access to health data 
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 Threats (part 2) 
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ACADEMIA / RESEARCH 
• Reduced number of international students because of tuition fees 
• Shortage of engineers, life science and healthcare professionals 
• Academic qualifications based on scientific publications does not stimulate 
commercialization of inventions 
• Intellectual property - current set-up of ownership of IP does not promote 
commercialization 
• Hard to get access to health data (data protection laws) 
• Costly to get access to health data 
 
HEALTH CARE 
• Shortage of healthcare professionals 
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 Analysis 
This chapter shows the analysis of the regional SWOT and the process to get 
strategies and action from it. The section ends with a broader analysis of the 
regional conditions for innovation in eHealth. 
8.1 Ranking the outcome 
After the SWOT for the region where preformed it’s time to analyze the result. 
The list from the SWOT analysis is consisting of a great number of strength, 
weaknesses, opportunities and threats. It´s a common thing to have a large 
number of factors but this makes it hard to work with. To reduce the number to 
a more hand able figure a selection of the most important factors in each category 
need to be done. This is one of the most important steps as these elements will 
be used in the creations of the future actions and strategies. The ranking was 
performed by the project team with inputs and ranking from each member.  
8.2 TOWS 
Using the reduced list from the SWOT analysis it can be inserted into the TOWS 
matrix. At this stage the list is not ranked individually of importance, the number 
is only used for mapping the categories with each other’s. Strengths with 
opportunities, strengths with threats, and weakness with opportunities last 
weakness with threats.  
The goal is to get strategic options and actions building on the unique conditions 
of the region.  
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  Strengths 
1. Patient centered point of view 
from politicians, policy 
makers and healthcare leaders 
2. Key areas expertise ICT 
( sensor, mobile, design, 
camera, security), Life 
science and MedTech 
3. Strong experience in 
standardization from telecom 
industry 
4. Department of Biomedical 
Engineering (eHealth track) 
5. Healthcare professionals with 
great interest and ideas in 
eHealth 
6. Geographical location 
(Oresund) 
 
Weaknesses 
1. Clinical information system lack 
interoperability, low awareness 
of healthcare standards and 
certifications 
2. Unclear business models for 
eHealth solutions 
3. Working in silos 
4. Difficult access healthcare 
expertise, test beds and 
knowledge of customers' needs 
5. Old-fashioned IT infrastructure 
and EHR-system 
6. Lack of long term vision and 
strategy for eHealth 
7. The innovation support structure 
is fragmented  
8. Complex healthcare organization 
9. Lack of funding opportunities 
and capital 
Opportunities 
1. Product differentiation - 
MedTech/eHealth solutions (healthcare 
products vs. consumer products) 
2. Lifestyle and preventive care trend 
3. Flexibility in reimbursement model 
4. Local access to ICT experienced citizens  
5. Patient organization has a willingness 
and interest to contribute to eHealth 
innovation 
6. Structured gathering of healthcare data 
(e.g. bio banks, quality register) 
7. Empowerment of patients and citizens, 
will be a driving force for the 
development and implementation of 
eHealth 
 
• Cross boarder meetings, 
develop new products and 
services (S2,S5-
O1,O2,O7) 
• Show the benefits of 
proper use of data (S1-
O6) 
• Look into the use of the 
existing reimbursement 
model (S2,S4-O3) 
• Gather and spread patients 
and customers need to the 
academia and business 
(S2,S4-O5) 
• Use the reimbursement 
model to create and 
communicate new business 
models for eHealth (W2-O3) 
• Look into the commercial 
side of eHealth, outside of 
healthcare (W9-
O1,O2,O4,O7) 
 
Threats 
1. Too complex business models (who will 
pay for it?) 
2. Too long time to market for eHealth 
solutions and unclear regulations results 
in business avoiding healthcare market 
3. Hard and costly to get access to health 
data 
4. Stockholm's lack of interest in the region 
5. Lagging behind key players in Europe 
6. Fragmented healthcare market (20 
regional council and large number of 
municipalities 
 
• Form closer strategic  
relations with 
Copenhagen (S6-T5) 
• Use department of 
Biomedical Engineering 
for promoting the region 
(S4-T5) 
• Lobby the benefits of 
access and use of health 
data to politicians (S1-T3) 
• Promote the region both 
national and international 
(W9-T5) 
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8.2.1 Strength and Opportunities (SO) 
• Cross boarder meetings, develop new products and services (S2,S5-
O1,O2,O7) 
Combining the ICT expertise in the region with the health care professionals 
and patients to get hold of ideas and real needs from within. There is a great 
possibility in product differentiation and use of position innovation when 
looking at healthcare and consumer products.  
 
• Show the benefits of proper use of data (S1-O6) 
At the moment it’s hard to get hold of all the structured healthcare data that’s 
gathered (e.g. bio banks, quality register). This data is a goldmine of 
information but it can’t be used today because of the regulation and laws. 
Therefore is it important to lobby and show the benefits of proper use of 
anonym’s unidentified data to politicians and policy makers. How the use of 
data can help the quality of life for the citizens and patients.  
 
• Look into the use of the existing reimbursement model (S2,S4-O3) 
There is a presumption that the current reimbursement model doesn’t favor 
innovation in digital healthcare with focus on preventive care. An expert in 
the area from healthcare opposes this belief and argues that in Skåne, this is 
entirely possible. An important action is to look into the existing 
reimbursement model and consult expert both form healthcare, business and 
the academia to evaluate new business models built upon the existing model.  
 
• Gather and spread patients and customers need to the academia and business 
(S2,S4-O5) 
Patient organizations is sitting on a lot of knowledge about their specific 
dieses and patients. The organizations are a good way to reach out and gather 
real need from the patients, ideas for how to improve the healthcare services 
and their every day of life. This is information the patient today doesn’t share 
with the healthcare system but rather with their peer group and patient 
organization. 
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8.2.2 Strength and Threats (ST) 
• Form closer strategic relations with Copenhagen (S6-T5) 
The region should use the geographical closeness to Denmark and the fact 
that they are a part of Medicon Valley. A good strategic relation would be 
beneficial for both regions. Both in terms of market and knowledge sharing.  
 
• Use department of Biomedical Engineering for promoting the region (S4-
T4,T5) 
The department of Biomedical Engineering with an eHealth track is a unique 
program which should be use to promote the region. Both to raise the 
awareness from Stockholm and to attract international business and capital to 
the region. Could be used to compete with Kalmar to get e-hälsomyndigheten 
to decide to locate in the region if that is a strategic goal.  
 
• Lobby the benefits of access and use of health data to politicians (S1-T3) 
Lobbying the benefits of access and the use of health data should be used to 
both national and local politicians. The security and integrity laws should be 
revisited. A possible solution might be to also create laws to punish misuse 
of information instead of focusing on security and locking it up in a vault. 
Safety is an important aspect to uphold but it shouldn’t hinder the use of 
information. Sweden should be in the forefront of innovation and open up un-
personified data for research and development. 
8.2.3 Weaknesses and Opportunities (WO) 
• Use the reimbursement model to create and communicate new business 
models for eHealth (W2-O3) 
In order to address the weakness of unclear business models actions should 
be done to look into existing reimbursement models and how it can be used. 
It´s important to communicate the results and findings. 
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• Look into the commercial side of eHealth, outside of healthcare (W9-
O1,O2,O4,O7) 
A possible way to address the lack of funding is to look more into the 
commercial side of eHealth. The region has local access to early adopters and 
ICT experience citizens. Launching a product on the commercial part of the 
market can be easier and then use the customers to demand and push it into 
the healthcare.  
8.2.4 Weaknesses and Threats (WT) 
• Promote the region both national and international (W9-T5) 
It’s important to when using the strengths and opportunities in the region to 
think about promoting Skåne both national and international. The region is 
lacking funding’s and Stockholm is not showing really interested in the 
region. Therefore it´s important to raise the awareness and advertise the 
region as a good place for innovation in digital healthcare. 
8.3 Analyze 
Skåne got a god political climate for innovation in healthcare. According to the 
survey most politicians have a patient/citizens point of view and see the benefits 
from new technological advances in the field. The region has an innovation 
agenda with the goal to be one of the most innovative regions year 2020. In the 
International Innovation strategy for Skåne personal health is represented as a 
possible field for advancement. The nation as a whole has a strategy for eHealth, 
Nationell eHälsa. Combining the strategies shows that eHealth is considered an 
important field for the future of healthcare. To make it easier for innovative 
uptake in healthcare all parts agree that the PCP and PPI need to be established 
and used. Without a new way into the public sector it’s hard for entrepreneurs or 
new players to enter. Today’s procurements doesn’t favor radical innovation as 
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much as process innovation, often the cheapest offer wins the procurement 
contract. Depending on the procurement some underlying needs might not 
surface. In May 2014 made the Swedish Competition Authority and VINNOVA 
an agreement to work on PPI. This means that they shall encourage the promotion, 
supply methods and support for innovation procurement. At the current time for 
this thesis no outcome from the collaboration has been presented. This is a 
collaboration that should be monitored and a goal for Region Skåne could be to 
try to become a test bed for PCP and PPI.  
An important factor raised from the business sector and healthcare is the nature 
and longevity of a procurement.  The winning player need to be able to support 
the product or service for an extended amount of time. Depending on the 
product/service this might make it hard for a single entrepreneur to get a contract 
and in such case a joint venture with an established player might be needed. The 
pharmaceutical industry might be a good partner for this type of ventures. They 
have worked with the healthcare regulations for decades. The industry is going 
through a time of changes. Patents are starting to expire and generic drugs are 
taking market shares. Looking into digital healthcare might be a chance for the 
pharmaceutical companies to diversify their portfolio, develop new kinds of 
value adding products and services. AstraZeneca presented at a local event that 
they are already looking into this field. 
8.3.1 Knowledge and expertise 
Skåne is today one of Europe’s most innovative regions. To gather good ideas 
and help new innovation out on the market Region Skåne has started Innovator 
Skåne. Innovator works a springboard pitching out the idea to potential partners 
who can and take it to the next level. This organization is relative known among 
the employees in Region Skåne but sense its start in September 2013, 283 ideas 
have been submitted but only a few has reached potential partners and even less 
the market. Innovator might not be the right way to go for everyone. Looking at 
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the business and academia it comes clear that they getting hold of healthcare 
expertise and customers need is the two biggest challenges. Healthcare on the 
other hand don’t have the time to elaborate their ideas. Talking about innovation 
there is two distinct types, radical- and incremental innovation. When many 
people think about innovation they think about the big radical ones, e.g. steam 
engine, electricity, and forget about all the incremental that helps to refine it. A 
good source to get incremental ideas is from the people on the floor using the 
product or service. These innovations and ideas can be in any of the four 
innovations types, product, process, position or even paradigm. Therefor getting 
hold of what healthcare professionals and customers/patients think most be 
considered important. Here can Region Skåne or an organization fill an important 
role to be the link from healthcare, patients to the business and academia. To 
facilitate cross boarder meetings and organize events for co-productions and 
information sharing.  
8.3.2 Financial Capital  
Looking at the financial aspects access to long-term funding’s is an important 
factor and an area where the region is lacking. Especially when going from the 
start phase into the growth phase. This even though 96 innovation companies is 
located in the region. From attended events it’s clear that Stockholm considered 
themselves as the innovative capital of Scandinavia. They are not looking at or 
promoting the southern parts which makes it harder for a region like Skåne to 
attract outside investors. Promoting the region and a try to raise the awareness 
both nation and international should be an important action. Region Skåne should 
also use the fact that they are a part of Medicon Valley, the Øresund region and 
close distance to Copenhagen. Denmark have come a long way on some fronts 
and a closer relationships should be beneficial for both regions. Like the market 
development-fund to help companies with their products on their final way to the 
markets. There is some cultural and social aspects affecting the movement of 
people. It´s hard to get people to travel from Malmö to Lund to come to meetings 
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or events, it´s even harder to get people to travel over the bridge. It’s a good thing 
to keep in mind but not an obstacle that cannot be overcome. 
8.3.3 Standards 
Looking at the regional strengths there is a great expertise in development 
standards derived from the mobile industry. This knowledge is something the 
region should try and capitalize on. Both the business and academia have a low 
awareness about medical standards. The healthcare is not using global 
interoperability standards. It’s important to raise this awareness to promote 
interoperability between systems. The region and Sweden should form strategic 
alliances with interoperability and standardization organizations such as 
Continua, at the moment some work is starting to be done on a national level. 
Skåne and Sweden is such a small market that if a company wants to go global 
the use of international standards is almost considered a most. Especially with 
potential outcome from the collaboration formed between the United States and 
United Kingdom. 
8.3.4 Fractured organization 
To capitalize on all the strengths it’s important to have a solid organization. The 
fact that Region Skåne is perceived as a fractured organization by stakeholders 
is something that needs to be addressed. There should be established a part of the 
organization that are responsible for innovation in healthcare and acts as a front 
into the healthcare. Might even use the concept developed by Hennepin County 
Medical Center and appoint a Chief Imitation Officer. A person whose job is to 
look outside the organization for good ideas to bring back. Taking inventions and 
innovations from around the world, improve and later applied them to the own 
organization. This is an approach well known to businesses outside of healthcare, 
Procter and Gamble have developed their concept C&D, Connecting and 
Developing. Taking ideas from outside and refine them for the companies 
specific needs and launch them on the market. For this to work it´s important to 
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get away from resistance to innovations from outside “not invented here” 
syndrome to “proudly found elsewhere”. This drastically changed their R&D 
organization “from 7,500 people inside to 7,500 plus 1.5 million outside”. 
(Huston and Sakkab 2006) 
When looking at the organization it´s important to follow the work around value-
based healthcare and the outcome. A shift in the compensation model to a more 
horizontal approach could drastically change the healthcare system. This is an 
area that is interesting to look into, as the joint study showed an increased 
productivity and satisfied patients when changing the care chain. 
8.3.5 Empowered patients and homecare  
One way to manage the upcoming demands might be to give more responsibility 
to the patients themselves. Giving away reasonability includes not just a 
responsibility to keep a healthy life style and try to prevent diseases, but also to 
take an active participation in case of a disease. Moving more advanced 
healthcare home to the patients themselves, advance home care, is one other way. 
By doing healthcare activities in the patients home hospitals can free up beds and 
therefore cope with a higher demand without investing in new hospital buildings. 
One active projects in advance home care in the region is itACiH, IT-stöd för 
Avancerad Canservård i Hemmet. The project is a cross boarder collaboration 
with eleven different partners from different sectors like business, academia and 
healthcare. It´s partly funded by VINNOVA in context of its focus on challenge 
driven innovation. There is an experience that patients prefer to be treated at 
home as long as they feel safe with the care provided. With the upcoming changes 
in the demographic pyramid and the expected rise of cancer patient homecare 
becomes an attractive opportunity that may reduce overall costs. In a longer 
perspective the project aim to use the knowledge gathered to support other groups 
of patients. The big questions is how to implement the solutions into the 
healthcare system and with a consortium like this who will be the provider.  
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8.3.6  Product examples 
Outside on the global market there is some good examples of both product, 
process and position innovations going on in the digital healthcare and healthcare 
sector.  
Google glass, a convenient way of displaying information in your field of view, 
now being tested and used in clinical environment on hospitals around the world.  
The Swasthya Slate, an off-the-shelf Android tablet combined with cheap sensors, 
processors, and other components. The result a platform with the capability to 
monitor electrocardiogram measures, blood pressure, blood sugar, urine protein, 
and several other biometrics. All this to a fraction of the cost of a comparable 
device and still having an accuracy within 99% of far more complex machines. 
Not everything need to be measured to a thousandth of a degree, take the body 
temperature as an example. People are fine with a tenth of a degree and value 
portability, size and price instead. Could this type of process and position 
innovations change the healthcare? 
The introduction of AI decision systems is not a question of if rather than when 
it will happen. An example from the Mayo Clinic, their system got algorithms to 
detect brain aneurisms in processed images and predict how likely it’s a correct 
answer. The systems has a 95 percent accuracy of detecting aneurysms and since 
it was introduced made significantly improvements in patient outcomes. The 
clinic also recently announced a partnership with IBM’s Watson team to use the 
natural language processing and data analytics capabilities of Watson. The goal 
is to help them ensure that eligible patients are considered for clinical trials and 
in the long run use it to accelerate medical research. With the help of cloud 
computing and mHealth applications this type of AI could in the future be more 
portable. This will as any mobile application put high demands on security within 
the applications and the communication between devices.  
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 Conclusions and Recommendations 
This chapter presents the conclusions of the regional preconditions in Skåne for 
innovation in digital healthcare. It ends with a list of complementary actions that 
that have come to light during the process. 
9.1 Regional preconditions in Skåne for innovation in digital healthcare 
Skåne got the possibilities for a good climate for innovation in healthcare. There 
is a possibility to gather ideas and projects for incremental innovation in the 
region. Both the healthcare professionals and patients are sitting with unused 
valuable expertise and knowledge. To get a more radical change in the healthcare 
sector some barriers need to be broken down. These changes need a more 
strategic and political approach, many of them need to be brought up on a national 
level. Today security laws regulation the use of information need to be modified 
to allow the use of unidentified healthcare data. Making it easier for the academia 
and companies to use this information would allow them to pursue new research 
areas and possible innovations in the field.  
For new entrepreneurs and business there need to be clear how to use the 
reimbursement model to support their business plans. There is also important that 
the way into the healthcare sector, procurements, is built to handle and promote 
these new ventures.  
Skåne has a gap in expertise regarding semantic interoperability, both in the 
business and academic sector. This is not a unique problem for Skåne and can be 
seen in other regions as well. Collaborations with other regions and worldwide 
expertise is needed to fill this gap and promote advances in this field. 
Comparing to other countries, Sweden are ranked 3rd on the list of innovation 
uptake in healthcare just beaten by Denmark and Estonia. Estonia has had the 
opportunity to build their whole system and infrastructure from the ground up. 
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It´s a country who has in the last decades been able to leapfrog over some old 
technologies and now can able considered one of the most advanced society when 
looking at ICT implementations. Sweden on the other hand was one of the first 
countries in the world where healthcare embraced and become computerizes. 
This are resulting in a broad knowledge about working in computer system. On 
the other hand Sweden’s healthcare system is built upon a computer system built 
in the 90ties.  This resulting in some of the interoperability’s seen today. The IT 
system of Region Skåne consist of over 700 different individual computer 
systems. Interoperability problems comes with this type of structure. 
9.2 Thought on the research methodology 
Using the TOWS matrix to analyses the SWOT and identifying and proposing 
innovative digital health strategies and actions has been effective. One thing that 
would have improve the thesis and the outcome would been to benchmark the 
region against other regions. Learning from best practice and other deployed 
innovative strategies. This could be regions from Denmark or Estonia ranking 
high on the innovation uptake in healthcare or from a totally different innovative 
sector like Silicon Valley in California.  
When preforming the interviews it would have been preferably to be two rather 
than one person. The benefits would be to have one asking the questions and 
being totally focused on the person being interviewed, and the other taking notes 
and checking body expressions from both the interview and interviewer. This to 
not miss anything.  
9.3 List of strategies and actions 
Down below is list of strategies and actions Region Skåne and University should 
look into. These are actions from the TOWS analysis and others that has come to 
light during the process.  
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9.3.1 Region Skåne 
• Make a single point of entry for entrepreneurs, business and academia to get 
into the healthcare system. To be a link from healthcare and patients to 
businesses and academia. In the same time address fact that Region Skåne is 
perceived as a fractured organization by its stakeholders. 
• Facilitate cross boarder meetings and organize events for co-productions and 
information sharing. 
• Lobby the benefits of allowing the use of unidentified healthcare data to 
politicians, policy makers and healthcare leaders. Making it easier for the 
academia, entrepreneurs and businesses to use this information would allow 
them to pursue new research areas and possible innovations in the field.  
• The region should form strategic alliances with interoperability and 
standardization organizations. Learn from Denmark who already doing this.  
• Form closer strategic relations with Copenhagen.  
• Look into the outcome of Denmark’s market development-fund. 
• Keep on working with the innovation structure to promote collaboration and 
create a shared vision for the region. This is a way to overcome the fragmented 
structure and make it easier for entrepreneurs. The long term agenda is to get 
Skåne known outside the region as a good place for new businesses and 
entrepreneurs. 
• Look into the existing reimbursement model and consult expert both form 
healthcare, business and the academia to evaluate new business models built 
upon the existing model. 
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• Use the department of Biomedical Engineering, Medicon Valley, the Øresund 
region and close distance to Copenhagen to promote and raise the awareness 
both nation and international. 
• Monitor the collaboration between Competition Authority and VINNOVA. A 
goal for Region Skåne could be to try to become a test bed for PCP and PPI. 
• The University’s should have access to EMR. Doctors and nurses should be 
able to get trained in the EMR before going out on their practice. Therefore a 
new procurement of an EMR system should include an education version.  
9.3.2 Academia 
• Data analytics and scientist will have a big role in the upcoming years. Gartner 
finds that by 2015 the demand for data and analytics resources will reach 4.4 
million jobs globally, but only one-third of those jobs will be filled. This will 
not only affect healthcare but most other industries.  
• Should open up the course eHealth to all faculties on LTH. Innovation in 
healthcare needs a multidisciplinary team with a wide range of expertise. 
Interdisciplinary collaborations is important and LTH has a wide range of 
faculties with all their own unique competencies.  
• Should be a revalidation of the tuition fees. Sweden will need more engineers 
and human capital in the years to come. One way is to get free mover-students 
who after their education decides to stay and work in the country.  
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 Reflections over the main contributions 
This chapter adds some reflections regarding the innovation in healthcare in 
Skåne. The chapter ends with some interesting question has come to light during 
the process and could be considered topics for future academic research. 
10.1 Regional preconditions in Skåne for innovation in digital healthcare 
Third place in eHealth solution implementation is good but we can’t sit down and 
be satisfied with the result.  Even if you are in first place you need to constantly 
revaluate your position and look for areas to improve. Sweden and specially 
Skåne with Øresund Region have things to learn from our neighbors in Denmark.  
“EHealth development in Estonia was certainly helped by the good cooperation 
with healthcare service providers and doctors”, explained Raul Mill, Member of 
the Board of the Estonian eHealth Foundation 
The region have most of the building blocks to get a good climate for innovation 
in digital healthcare. We need to join the blocks together, here has an organization 
a unique opportunity to facilitate cross-border meetings, be a collaborate voice, 
and put digital healthcare on the agenda. There is a need for a link into healthcare 
to get providers, doctors and nurses to share their ideas and needs to business, 
entrepreneurs, and the academia. Lobbying to politicians and policymakers 
should be done to raise the awareness and try to change some regulations and 
laws that acts as barriers for innovation today.  
“Perhaps what we need is not simply another “big idea”, but rather better ways 
of distributing the smaller ideas.” 
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10.2 Topics for future academic research 
During the process some question has come to light that might be interesting for 
further academic research. 
• How does the academic reimbursement model effect inventions, innovations 
and commercialization? Compare to Denmark. 
• How can the existing reimbursement model be used to compensate proactive 
healthcare? 
• How did the introduction of tuition fees affecting the Universities and the 
innovation climate in Sweden? 
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10.3  Digital healthcare projects in Skåne 
Here is a list of digital healthcare projects in Skåne gathered from the READi for 
Health survey.  
• E-journal  
• E-tjänsten mina vårdkontakter  
• EU projekt om hjärtsvikt med elektronisk våg och blodtryck i hemmet 
med överföring och till detta ett interaktivt utbildningspaket. dessutom 
finns ett antal påbörjade projekt från koncernrådet för eHälsa. 
• HSA/Katalogtjänst  
• Samordnad vårdplanering på distans  
• Patologi på distans 
• Digitala utbildningar för personal inom vård och omsorg 
• Telemetri 
• itACiH 
• Genomfört proof of concept 2009 för diabetesuppföljning. 
• KOL-projektet Infracloud-projektet med Region Skåne och Ericsson 
• Digitaliserat beslutsstödet RETTS/Predicare  
• Simulator för käkkirurgi  
• Tandläkarstudenter  
• Arbetat med teknik för att behandla cancer  
• Cellnovo 
• Trialbee 
• En ny digital och mobil upplaga av Triagehandboken. 
• Cellavision, använding av Smarta Vågar, etc 
• Många olika appliaktioner såsom distansronder, signalhantering ( 
 ekg-tagning) mm 
• Juvopal 
• Take Good Care AB,  
• Lund Medical AB,  
• Dianovator AB (m-health) 
• CardioLund Research AB 
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Appendix 1. Survey results 
 
 
Figure 9 (Business) We use the following medical terminology/standards in our 
business… (multiple answers allowed) 
Figure 10 (Academia) We use the following medical terminology/standards in our 
research… (multiple answers allowed) 
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 Figure 11 in our organization we primarily use … crossed with our responsibility is… 
 
Figure 12 in our organization we primarily use…  
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Figure 13 The 3 major difficulties/ barriers in creating eHealth innovations based on ideas from our 
healthcare professionals are... 
 
Figure 14 (Business) Our company/research group is collaborating with... (multiple answers allowed) 
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 Figure 15 (Academia) Our company/research group is collaborating with... (multiple answers allowed) 
 
Figure 16 (Business) The 3 most important factors for our business to be able to develop innovative 
products are... 
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 Figure 17 (Academia) The 3 most important factors for our business to be able to develop innovative 
products are... 
 
Figure 18 (Academia) The 3 major challenges in creating eHealth innovations for our business are... 
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 Figure 19 (Business) The 3 major challenges in creating eHealth innovations for our business are... 
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Appendix 2. Djupintervjufrågor – Akademi 
Forskning 
Datum:_________________    
Namn: ______________________________Titel:____________________ 
Universitet:_____________________Institution:_______________ 
Vilka faktorer är viktigast för att stimulera er forskning? 
Vad har ni? Vad saknar ni? 
Finansiering, partnerskap företag/kunder, intressegrupper, samarbetspartners, testbäddar, 
marknaden, stöd inom internationalisering 
Bedriver ni forskning inom området e-hälsa? Alternativ forskning som kan appliceras 
på e-hälsa? 
Vilka områden anser du kommer vara nyckelområden för vidare utveckling? 
Exempel på hur er forskning lett till framgångsrika innovationer inom e-hälsa?  
Andra framgångsrika exempel på innovationer inom e-hälsa i regionen? 
Vilka barriärer har ni stött på? 
Hur kan man underlätta dessa? 
Hur ser ni på de regulatoriska krav som ställs? 
Vilka möjligheter och utmaningar har ni stött på i er forskning inom e-hälsar? 
Vad har ni gjort för att komma över dem? 
Hur samverkar ni för att bygga upp kompetenserna kring e-hälsa?  
Vilka forum saknar ni? 
Några exempel på erfarna forskare inom e-hälsa? 
Vilka är nyckelaktörerna för ett framgångsrikt e-hälsoprojekt/ utveckling av e-
hälsoprodukter? 
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Vilka tycker du är de främsta styrkorna i regionen för att stimulera innovationer inom 
e-hälsa, locka till sig investeringar och företagsetableringar? 
På vilka områden är regionen svagare? 
Hur kan vi övervinna dessa svagheter? 
I vilka konstellationer kommer innovation och produktutvecklingen att ske? 
Vad behöver göras för att katalysera och facilitera utvecklingen av e-hälsoprodukter? 
Varför händer det inte? 
Vad behövs för att bygga upp denna bransch/ skapa en marknad? 
Möten över gränser, vilka konstellationer ser ni som framgångsrika? 
Hur skapar man en sprudlande verkstad för e-hälsa? 
Vilket stöd behövs? Från vem? 
Hur ser ni på rådande intäktsmodell, finansiering för att driva e-hälsoinnovation? 
 
Vem betalar för proaktiv sjukvård? 
 
Några förslag på förändringar som behöver ske? 
 
Vilka anser du är de viktigaste områdena att bedriva forskning och utveckling med 
avseende på e-hälsa? 
 
Ytterligare information som du vill dela med oss?  
 
Nyckelpersoner som du tycker att vi bör kontakta? 
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Appendix 3. Djupintervjufrågor – Hälso- och 
sjukvård 
Datum:_________________    
Namn:_______________________Titel:____________________ 
Organisation:__________________O /P:____________________ 
 
Vilka IT stöd använder ni i vardagen? 
Vilka elektroniska lösningar efterfrågas? Underliggande behoven? 
Hur uppfattas IT i organisationen? 
Finns det en strategi för upptag av idéer från medarbetare som kan ledda till 
innovationer? 
Ja: Hur välkänd är den ute i organisationen? 
Nej: Varför inte? 
Vilka möjligheter och utmaningar har ni stött på vid implementering utav e-
hälsolösningar? 
Vad har ni gjort för att komma över dem? 
Hur samverkar ni för att bygga upp kompetenserna kring e-hälsa?  
Vilka forum saknar ni? 
Vilka är nyckelaktörerna för ett framgångsrikt e-hälsoprojekt/ implementering av e-
hälsolösningar? 
Vilka tycker du är de främsta styrkorna i regionen för att stimulera innovationer inom 
e-hälsa, locka till sig investeringar och företagsetableringar? 
På vilka områden är regionen svagare? 
Hur kan vi övervinna dessa svagheter? 
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I vilka konstellationer kommer innovation och produktutvecklingen att ske? 
Vad behöver göras för att katalysera och facilitera utvecklingen av e-hälsoprodukter? 
Varför händer det inte? 
Vad behövs för att bygga upp denna bransch/ skapa en marknad? 
Möten över gränser, vilka konstellationer ser ni som framgångsrika? 
Hur skapar man en sprudlande verkstad för e-hälsa? 
Vilket stöd behövs? Från vem? 
Vilka anser du är de viktigaste områdena att bedriva forskning och utveckling med 
avseende på e-hälsa? 
 
Hur ser ni på rådande intäktsmodell, finansiering för att driva e-hälsoinnovation? 
 
Vem betalar för proaktiv sjukvård? 
 
Några förslag på förändringar som behöver ske? 
 
Ytterligare information som du vill dela med oss?  
 
Nyckelpersoner som du tycker att vi bör kontakta? 
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Appendix 4. Djupintervjufrågor – Näringsliv 
Datum:_________________    
Namn: ______________________Titel:____________________ 
Organisation:_________________________ 
Har ert företag utvecklat e-hälsoinnovationer / produkter? 
Vilka barriärer finns för kommersialisering? 
Hur kan man underlätta kommersialisering? 
Hur ser ni på de regulatoriska krav som ställs? 
Vilka möjligheter och utmaningar har ni stött på i ert arbete med e-hälsoinnovationer? 
Vad har ni gjort för att komma över dem? 
Hur samverkar ni för att bygga upp kompetenserna kring e-hälsa?  
Vilka forum saknar ni? 
 
Några exempel på erfarna entreprenörer inom e-hälsa? 
 
Vilka är nyckelaktörerna för ett framgångsrikt e-hälsoprojekt/ utveckling av e-
hälsoprodukter? 
 
Vilka tycker du är de främsta styrkorna i regionen för att stimulera innovationer inom 
e-hälsa, locka till sig investeringar och företagsetableringar? 
På vilka områden är regionen svag? 
Hur kan vi övervinna dessa svagheter? 
I vilka konstellationer kommer innovation och produktutvecklingen att ske? 
Vad behöver göras för att katalysera och facilitera utvecklingen av e-hälsoprodukter? 
Varför händer det inte? 
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Vad behövs för att bygga upp denna bransch/ skapa en marknad? 
Möten över gränser, vilka konstellationer ser ni som framgångsrika? 
Hur skapar man en sprudlande verkstad för e-hälsa? 
Vilket stöd behövs? Från vem? 
Känner ni till Innovationsupphandlingar? 
 
Vad finns det för möjligheter, hinder och utmaningar? 
 
Hur ser ni på rådande intäktsmodell, finansiering för att driva e-hälsoinnovation? 
 
Vem betalar för proaktiv sjukvård? 
 
Några förslag på förändringar som behöver ske? 
 
Ytterligare information som du vill dela med oss?  
 
Nyckelpersoner som du tycker att vi bör kontakta? 
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